Bronstein, Gewirtz & Grossman, LLC Investigates TranS1, Inc.
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of TranS1, Inc. (“TranS1” or the “Company”) (NASDAQGM:TSON), concerning whether the company and certain of its officers and directors have violated federal securities laws.
On October 17, 2011, TranS1, the Wilmington-based medical device company, announced in a regulatory filing that on or about October 6, 2011, the federal government subpoenaed documents from them. The subpoena from the Department of Health and Human Services' Office of Inspector General is "under the authority of the federal health care fraud and false claims statutes," the company said in a filing with the Securities and Exchange Commission. According to the filing, the subpoena seeks documents from January 1, 2008, through October 6, 2011. Following this news, the Company’s shares plummeted nearly 40%.
If you are aware of any facts relating to this investigation, or purchased shares of TranS1, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.
Our primary expertise is the aggressive pursuit of litigation claims on
behalf of our clients. In addition to representing institutions and
other investor plaintiffs in class action security litigation, the
firm’s expertise includes general corporate work, private securities
offerings, and securities arbitration.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV